Weekly Executive & Director Moves (Sep 15)

by | Sep 15, 2023

Boardroom Alpha provides in-depth analytics and tracking of all public company executives and officers. Below is a rundown of people moves made at notable companies this past week. Get a demo today to see how you can receive real-time alerts and in-depth analytics.

Moves in this Issue

CEO

AMK, EXPR, FAZE, HLNE, HTIA, LAW, OFIX, TBI

CFO

AAMC, ARE, CCCC, CLMT, DLTH, FDMT, GERN, IEX, INGN, INSG, LEGH, MESA, MFA, NRXP, OC, OFIX, PIPR, PRAA, RCKY, RGEN, SBAC, SMTC, TTMI, VRDN

Directors

AAN, AFCG, ALLE, AMK, AMZN, BAX, BHLB, CECO, CMG, CRSP, CYH, DH, DNTH, DX, EFTR, ELME, EXPR, FAZE, FMCC, GNL, GNLX, HLF, HTIA, KMB, LAW, LOGI, LULU, MDAI, MKTW, MKTX, MLYS, NMIH, NSCT, OSBC, PLX, PRU, QBTS, RBLX, RWLK, SBUX, STCN, TBI, UGI, USGO, WWE

 

CEO MOVES

ASSETMARK FINANCIAL HOLDINGS INC (AMK)
Leaving: CEO – Natalie Grace Wolfsen ( 2.5 yrs; 4.8% TSR)
Replaced by: Michael Kim

Michael Kim – President, Chief Client Officer Mr. Kim has served as our President since March 2021 and our Chief Client Officer since January 2018. Mr. Kim joined our company in 2010 and previously served as our National Sales Leader from January 2018 to March 2021. Prior to becoming our Chief Client Officer and National Sales Leader, Mr. Kim served as our National Sales Manager from 2014 to 2018,…read full bio

CS DISCO INC (LAW)
Leaving: CEO – Kiwi Camara ( 2.2 yrs; -50.4% TSR)
Replaced by: Scott A Hill

Scott Hill has served as a member of our board of directors since June 2021. Mr. Hill most recently served as an advisor to the Chief Executive Officer of Intercontinental Exchange, Inc. from May 2021 to February 2023 and also served as its Chief Financial Officer from May 2007 to May 2021. Before that, Mr. Hill was an international finance executive for International Business Machines Corporation…read full bio

FAZE HOLDINGS INC (FAZE)
Leaving: CEO – Lee Trink ( 1.2 yrs; -94.6% TSR)
Replaced by: Christoph Pachler

Christoph Pachler has served as Chief Financial Officer of FaZe since October 2022 and as Chief Operating Officer since May 2023. Mr. Pachler oversees financial management, including financial planning, accounting and reporting, strategic development, M&A and investor relations, operational matters, and works closely with the executive team on strategies to develop new revenue opportunities and dr…read full bio


HAMILTON LANE INC (HLNE)
Leaving: CEO – Mario L Giannini ( 23.0 yrs; 30.1% TSR)
Replaced by: Juan Delgado-Moreira

Juan Delgado-Moreira Mr. Delgado-Moreira was named a Vice Chairman in 2018 and serves as the head of our Asia business. He is a member of various HLA investment committees and leads our Asian investment activities and client relationships. Prior to joining the firm in 2005, Mr. Delgado-Moreira was an Investment Manager at Baring Private Equity Partners Ltd. in London, where he focused on mid-marke…read full bio

HAMILTON LANE INC (HLNE)
Leaving: CEO – Mario L Giannini ( 23.0 yrs; 30.1% TSR)
Replaced by: Erik R Hirsch

Erik R. Hirsch Mr. Hirsch has served as a Vice Chairman since 2016 and is a member of our board of directors. He is also Head of Strategic Initiatives and a member of various investment committees of HLA. Prior to becoming our Vice Chairman, he previously served as Chief Investment Officer of HLA from 2003 to 2016. Prior to becoming Chief Investment Officer, Mr. Hirsch held the positions of Managi…read full bio

ORTHOFIX MEDICAL INC (OFIX)
Leaving: CEO – Keith Valentine ( .7 yrs; -6.9% TSR)
Replaced by: Catherine M Burzik

Ms. Burzik, age 72, was appointed Chair of the Board in June 2023. She previously served as the Chair of the Orthofix Board from 2021-2022 before assuming the position of Lead Independent Director in January 2023. She previously served as President and Chief Executive Officer of Kinetic Concepts, Inc., a global medical device company, from 2006 until the company’s sale in 2011. Prior to that, Ms. …read full bio

TRUEBLUE INC (TBI)
Leaving: CEO – Steven C Cooper ( 1.3 yrs; .5% TSR)
Replaced by: Taryn R Owen

Taryn R. Owen , 44, has served as President and Chief Operating Officer of the Company since September 2022, after serving as Executive Vice President of the Company and President of PeopleReady, TrueBlue’s general, industrial and skilled trade staffing business, and PeopleScout, TrueBlue’s recruitment process outsourcing (“RPO”) and managed service provider (“MSP”) solutions business, since Octob…read full bio

CFO Moves

ALEXANDRIA REAL ESTATE EQUITIES INC (ARE)
Leaving: CFO – Dean A Shigenaga ( 18.8 yrs; 6.1% TSR)
Replaced by: Marc E Binda
 
Mr. Binda, age 47, has served as Executive Vice President – Finance & Treasurer since June 2019. Mr. Binda previously served as Senior Vice President – Finance & Treasurer since April 2018, as Senior Vice President – Finance since April 2012, and in other capacities from January 2005 to April 2012. Since joining the Company, Mr. Binda has served in a variety of positions of increasing responsibili…read full bio

C4 THERAPEUTICS INC (CCCC)
Leaving: CFO – Lauren White ( 2.3 yrs; -65.7% TSR)
Replaced by: Kendra Adams
 
Ms. Adams joined C4T in November 2020 as senior vice president, investor relations & corporate communications and a member of the company’s management team. She has more than twenty-five years of experience in financial, operational and strategic planning. For nearly twenty years, Ms. Adams has worked in the biotechnology sector where she has developed investor relations progr…read full bio

INOGEN INC (INGN)
Leaving: CFO – Kristin A. Caltrider ( 1.5 yrs; -63.5% TSR)
Replaced by: Michael K Sergesketter
 
Michael Sergesketter has served as our Executive Vice President, Chief Financial Officer since December 2021. Mr. Sergesketter most recently served as CFO of Kimball Electronics, Inc Mr. Sergesketter brings over forty years of finance experience in the manufacturing services industry. He brings expertise working across business functions, including with the CEO and Board of Directors, Audit Commit…read full bio

MESA AIR GROUP INC (MESA)
Leaving: CFO – Daniel Torque Zubeck ( 1.9 yrs; -57.1% TSR)
Replaced by: Michael Lotz
 
Michael J. Lotz . Mr. Lotz serves as our President, and has been with us since 1998, serving as President since 2000. Mr. Lotz also served as our Chief Financial Officer from 1998 to October 1, 2021. From 1995 to 1998, Mr. Lotz worked with Mr. Ornstein, first at Continental Express as senior director of purchasing, later as vice president of airport operations, and then at Virgin Express S.A./N.V….read full bio

MFA FINANCIAL INC (MFA)
Leaving: CFO – Stephen D Yarad ( 13.0 yrs; 5.1% TSR)
Replaced by: Michael Charles Roper
 
Mr. Roper, 36, who has held various accounting and financial reporting-related positions since his joining the Company in 2014, has been Senior Vice President of the Company since January 2019 and Chief Accounting Officer of the Company since December 2021, and he will continue in these roles. Biographical information regarding Mr. Roper has been previously reported in the Company’s 2023 Proxy Sta…read full bio

ORTHOFIX MEDICAL INC (OFIX)
Leaving: CFO – John J Bostjancic ( .7 yrs; -6.9% TSR)
Replaced by: Geoffrey C. Gillespie
 
Mr. Gillespie, age 52, has served as the Vice President, Corporate Controller of Orthofix since May 2021, and previously served as Senior Director of U.S. Accounting and Consolidations at the Company from August 2013 until his promotion in 2021. Prior to joining Orthofix, Mr. Gillespie held various financial reporting management roles at Flowserve, and prior to that, at Deloitte for over seven yea…read full bio

PIPER SANDLER COMPANIES (PIPR)
Leaving: CFO – Timothy L Carter ( 6.3 yrs; 14.6% TSR)
Replaced by: Katherine P. Clune
 
Ms. Clune, 43, most recently served as Treasurer and Head of Planning and Strategy at Evercore Inc., a global independent investment banking advisory firm, from June 2022. Prior to that, Ms. Clune served in various capacities with Morgan Stanley from 2005 through 2021, …read full bio

PRA GROUP INC (PRAA)
Leaving: CFO – Peter M Graham ( 7.1 yrs; -4.1% TSR)
Replaced by: Rakesh Sehgal

Mr. Sehgal, age 51, has served as the Company’s Head of Corporate Development since May 2022. From 2013 through March 2022, Mr. Sehgal held various positions of increasing responsibility with General Electric and GE Capital, including Managing Director, Corporate Development in the mergers and acquisitions group. Prior to his nine years with General Electric and GE Capital, Mr.&…read full bio

ROCKY BRANDS INC (RCKY)
Leaving: CFO – Sarah O’Connor ( .5 yrs; -38.9% TSR)
Replaced by: Thomas D Robertson

Thomas D. Robertson, 38, has served as Chief Operating Officer since November 2022. Prior to that, he served as Executive Vice President, Chief Financial Officer and Treasurer since May 2018 and as Vice President, Chief Financial Officer and Treasurer since March 2017. Before that, he served as Senior Financial Analyst since joining the Company in October 2016. Prior to that, from July 2015 until …read full bio

SEMTECH CORP (SMTC)
Leaving: CFO – Emeka Chukwu ( 16.9 yrs; 4.1% TSR)
Replaced by: Mark Lin

Mr. Lin, age 47, has served as Vice President and Corporate Controller of MKS Instruments, Inc., a global provider of foundational technology solutions to leading edge semiconductor manufacturing, electronics and packaging, and specialty industrial applications since November 2019. Previously, Mr. Lin was with Microsemi Corporation, a provider of semiconductor and system solutions, fr…read full bio

 

Director Joins

ALLEGION PLC (ALLE)
Sue Main

Main’s professional career spans private and public companies as well as commercial, government and industrial sectors across global markets. Most recently, as CFO of publicly traded Teledyne Technologies, Main has led and developed a best-in-class finance organization that’s supporte…read full bio


BERKSHIRE HILLS BANCORP INC (BHLB)
Mary Anne Callahan

Ms. Callahan will be considered an independent director. Ms. Callahan was also appointed to the Board of Directors of Berkshire Bank. Ms. Callahan, age 60, served most recently as a Managing Director in the Financial Services Group at Piper Sandler Companies. Prior to joining Piper Sandler, she was …read full bio



DEFINITIVE HEALTHCARE CORP (DH)
Scott G Stephenson

Stephenson held various roles at Verisk Analytics, Inc. (Nasdaq: VRSK), a strategic data analytics and technology partner to the global insurance industry, between 2001 and 2022, including nine years as chief executive officer and a member of the Board of Directors. Prior to joining Verisk, Steph…read full bio


EFFECTOR THERAPEUTICS INC (EFTR)
Caroline M Loewy

Caroline M. Loewy Director March 29, 2021 74 LOCUST WALK ACQUISITION CORP. INDEX TO FINANCIAL STATEMENTS Report of Independent Registered Public Accounting Firm F-2 Financial Statements: Balance Sheet F-3 Statement of Operations F-4 Statement of Changes in Stockholder’s Equity F-5 Statement of Cash …read full bio


GENELUX CORP (GNLX)
John W Smither

Mr. Smither most recently served as the chief financial officer of Arcutis Biotherapeutics, Inc. (“Arcutis”) from May 2019 to March 2021, where he was responsible for all financial aspects of Arcutis including lead…read full bio


KIMBERLY CLARK CORP (KMB)
Deeptha Khanna

Ms. Khanna is currently Executive Vice President and Chief Business Leader, Personal Health, for Royal Philips, a health technology company, a position she has held since 2020, while serving on the company’s Executive Commit…read full bio

 

MARKETAXESS HOLDINGS INC (MKTX)
Carlos Mauricio Hernandez

Carlos M. Hernandez Director since February 2006 Carlos M. Hernandez (56) is Head of Global Banking at JPMorgan Chase & Co., serves on the JPMorgan Chase Executive Committee and is a member of the Corporate & Investment Bank’s leadership team. Prior to this position, Mr. Hernandez was Global Head o…read full bio


MINERALYS THERAPEUTICS INC (MLYS)
Daphne Karydas

Ms. Karydas has served as President and Chief Financial Officer of Flare Therapeutics Inc., a pre-clinical pharmaceutical company, since October 2021. Prior to joining Flare, she served as the Chief Financial Officer of Syndax Pharmaceuticals, Inc., a publicly-held biopharmaceutical company, from Ju…read full bio


MINERALYS THERAPEUTICS INC (MLYS)
Glenn Sblendorio

Mr. Sblendorio was Chief Executive Officer and a member of the board of directors of IVERIC bio, Inc., a publicly-held biotechnology company, from July 2017 until it was acquired by Astellas Pharma in July of 2023. Prior to IVERIC, Mr. Sblendorio was President and Chief Financial Officer of The Medi…read full bio


SPECTRAL AI INC (MDAI)
Xiaojia Cynthia Cai

Dr. Cynthia Cai is an executive and investor with over twenty-five years of experience in the healthcare and life science industry. Extensive experience in equity investment, b…read full bio


SPECTRAL AI INC (MDAI)
Martin Cb Mellish

Martin Mellish has served as founding director of Aspen Advisory Services Ltd., since 1994. Aspen is a London-based private office overseeing investments in North America, Europe, and Asia. Mr. Melli…read full bio


SPECTRAL AI INC (MDAI)
Richard John Cotton

Richard Cotton has a wealth of experience in senior financial roles in life sciences and other sectors, including broadcast and photographic, automotive, filtration and metals. His experience covers all financial management and value creation activities from R&D, to manufactu…read full bio


SPECTRAL AI INC (MDAI)
Wensheng Fan

Wensheng Fan is a Co-Founder and the first employee of Spectral. For 11 years he served as CTO and COO, before becoming the CEO of Spectral. He is an executive, entrepreneur, and innovator with over 20 years of experience in n…read full bio


STEEL CONNECT INC (STCN)
Joseph Richards Martin

Mr. Martin, age 46, will begin service as a Director of the Company immediately after the Annual Meeting. Mr. Martin has been Chief Administrative Officer and Chief Legal O…read full bio


TRUEBLUE INC (TBI)
Taryn R Owen

Taryn R. Owen , 44, has served as President and Chief Operating Officer of the Company since September 2022, after serving as Executive Vice President of the Company and President of PeopleReady, TrueBlue’s general, industrial and skilled trade staffing business, and PeopleScout, TrueBlue’s recruitm…read full bio



US GOLDMINING INC (USGO)
Laura Schmidt

Ms. Schmidt is a global executive with over 30 years of worldwide experience in the oil/gas/new energy industry in Shell. She currently works in Supply Chain in Shell’s Upstream Directorate and has worked for Shell since 1990 in a variety of senior leadership roles across the globe. Ms. Sch…read full bio



US GOLDMINING INC (USGO)
Garnet Linn Dawson

Mr. Dawson served as the President of our Company from 2015 through September 12, 2022. Since 2018, Mr. Dawson has served as a member of the board of directors of GoldMining, a public company listed on the NYSE American and Toronto Stock Exchange; and Freegold Ventures Limited, a company listed o…read full bio


US GOLDMINING INC (USGO)
Lisa Jean Wade

Ms. Wade was appointed as a director of our Company on September 12, 2022, and serves as a member of the Company’s nominating and corporate governance committee and the Chairperson of the Company’s sustainability committee. Ms. Wade served as a member of the board of directors of Gold…read full bio


US GOLDMINING INC (USGO)
Alastair Charles Still

Alastair Still, Mr. Still is an experienced mining industry professional with over 25 years of experience including working for gold miners. Mr. Still currently serves as Chief Executive Officer of GoldMining and Director of Technical Services for Gold Royalty Corp., having held …read full bio


US GOLDMINING INC (USGO)
Ross Lawrence Sherlock

Ross Sherlock was appointed as a director of our Company on September 12, 2022, and serves as a member of the Company’s audit committee and compensation committee. Dr. Sherlock is a professional geologist with over 30 years of experience in the mining industry and academic research. Dr. She…read full bio

 

Director Leaves

AFC GAMMA INC (AFCG)
Jonathan Gilbert Kalikow ( 3.2 yrs; -8.7% TSR)


ASSETMARK FINANCIAL HOLDINGS INC (AMK)
Natalie Grace Wolfsen ( 2.5 yrs; 4.8% TSR)


BAXTER INTERNATIONAL INC (BAX)
Michael F Mahoney ( 7.9 yrs; 3.0% TSR)
Committees: Compensation, Nominating (and Governance), Public Policy, Quality, Compliance and Technology, Special Litigation

CRISPR THERAPEUTICS AG (CRSP)
Rodger Novak ( 5.8 yrs; 18.3% TSR)


CS DISCO INC (LAW)
Kiwi Camara ( 2.2 yrs; -50.4% TSR)


DEFINITIVE HEALTHCARE CORP (DH)
Christopher Mitchell ( 2.0 yrs; -54.0% TSR)


D-WAVE QUANTUM INC (QBTS)
Michael J Rogers ( 1.1 yrs; -83.8% TSR)


EFFECTOR THERAPEUTICS INC (EFTR)
John W Smither ( 2.1 yrs; -70.9% TSR)
Committees: Audit, Nominating (and Governance)

EXPRESS INC (EXPR)
Timothy G Baxter ( 4.3 yrs; -35.6% TSR)


FAZE HOLDINGS INC (FAZE)
Lee Trink ( 1.2 yrs; -94.6% TSR)


FEDERAL HOME LOAN MORTGAGE CORP (FMCC)
Michael J Devito ( 2.8 yrs; -42.3% TSR)


HEALTHCARE TRUST INC (HTIA)
Edward M Weil Jr ( 6.9 yrs; -2.7% TSR)


LOGITECH INTERNATIONAL SA (LOGI)
Michael B Polk ( 4.0 yrs; 16.2% TSR)
Committees: Compensation, Nominating (and Governance)

MAGENTA THERAPEUTICS INC (DNTH)
Amy L Drifka ( -42.7% TSR)
Committees: Nominating (and Governance)

MAGENTA THERAPEUTICS INC (DNTH)
Bruce Booth ( 7.6 yrs; -42.7% TSR)
Committees: Audit

MAGENTA THERAPEUTICS INC (DNTH)
David Scadden ( 5.3 yrs; -42.7% TSR)
Committees: Nominating (and Governance), R&D

MAGENTA THERAPEUTICS INC (DNTH)
Jeffrey W Albers ( 6.2 yrs; -42.7% TSR)
Committees: Audit, Compensation

MAGENTA THERAPEUTICS INC (DNTH)
Michael Vasconcelles ( 1.1 yrs; -50.3% TSR)


MAGENTA THERAPEUTICS INC (DNTH)
Thomas O Daniel ( 6.9 yrs; -42.7% TSR)
Committees: Compensation, R&D

MINERALYS THERAPEUTICS INC (MLYS)
Takeshi Takahashi ( 3.3 yrs; -31.0% TSR)


NATIONAL SCIENTIFIC CORP (NSCT)
Thomas Wiley Wilkinson ( 4.3 yrs; )


OLD SECOND BANCORP INC (OSBC)
James F Tapscott ( 7.9 yrs; 12.0% TSR)
Committees: Audit, Loan, Nominating (and Governance), Risk, Risk and Insurance

REWALK ROBOTICS LTD (RWLK)
Yasushi Ichiki ( 9.7 yrs; -54.3% TSR)


REWALK ROBOTICS LTD (RWLK)
Wayne Weisman ( 14.7 yrs; -54.3% TSR)
Committees: Audit

REWALK ROBOTICS LTD (RWLK)
Aryeh Dan ( 10.7 yrs; -54.3% TSR)
Committees: Compensation, Nominating (and Governance)

STARBUCKS CORP (SBUX)
Howard D Schultz ( 1.4 yrs; 17.2% TSR)


STARBUCKS CORP (SBUX)
Howard D Schultz ( 1.4 yrs; 9.4% TSR)


STEEL CONNECT INC (STCN)
Maria Molland ( 3.8 yrs; -7.1% TSR)
Committees: Audit, Compensation, Nominating (and Governance)

TRUEBLUE INC (TBI)
Steven C Cooper ( 17.3 yrs; -3.0% TSR)
Committees: Innovation and Technology

WORLD WRESTLING ENTERTAINMENT INC (WWE)
Steve Pamon ( 3.0 yrs; 34.5% TSR)
Committees: Audit, Nominating (and Governance)

WORLD WRESTLING ENTERTAINMENT INC (WWE)
Paul Levesque ( 8.6 yrs; 31.8% TSR)
Committees: Executive

WORLD WRESTLING ENTERTAINMENT INC (WWE)
George A Barrios ( .7 yrs; 48.4% TSR)
Committees: Audit, Executive

WORLD WRESTLING ENTERTAINMENT INC (WWE)
Michelle McKenna ( 1.0 yrs; 50.3% TSR)
Committees: Audit

WORLD WRESTLING ENTERTAINMENT INC (WWE)
Michelle D Wilson ( .7 yrs; 48.4% TSR)
Committees: Compensation & Human Capital, Executive, Nominating (and Governance)

WORLD WRESTLING ENTERTAINMENT INC (WWE)
Vincent K McMahon ( .7 yrs; 8.3% TSR)
Committees: Executive

WORLD WRESTLING ENTERTAINMENT INC (WWE)
Vincent K McMahon ( .7 yrs; 48.4% TSR)
Committees: Executive

WORLD WRESTLING ENTERTAINMENT INC (WWE)
George A Barrios ( .7 yrs; 38.8% TSR)
Committees: Audit, Executive

WORLD WRESTLING ENTERTAINMENT INC (WWE)
Michelle D Wilson ( .7 yrs; 38.8% TSR)
Committees: Compensation & Human Capital, Executive, Nominating (and Governance)

WORLD WRESTLING ENTERTAINMENT INC (WWE)
Steven R Koonin ( 2.3 yrs; 32.6% TSR)
Committees: Compensation & Human Capital, Nominating (and Governance)

 

Recent Analysis

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.